Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Insulin Resistance 5Hyperglycemia 3Polycystic Ovary Syndrome 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Oligomenorrhea 1Leukemia, Myeloid, Acute 1Leukemia 1Intracranial Aneurysm 1Hypoglycemia 1Hyperphagia 1Hyperinsulinism 1Hyperandrogenism 1Hirsutism 1Diabetes Mellitus, Type 1 1Congenital Abnormalities 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cytarabine 86fludarabine phosphate 85Peripheral Blood Stem Cell Transplantation 76Cyclophosphamide 69Busulfan 63Mycophenolic Acid 51Tacrolimus 48Cyclosporine 48Etoposide 43Whole-Body Irradiation 42Antilymphocyte Serum 40Methotrexate 39Filgrastim 39Flow Cytometry 30Radiotherapy 29Melphalan 24Mitoxantrone 23Daunorubicin 23Idarubicin 21Cord Blood Stem Cell Transplantation 19Polymerase Chain Reaction 17Methylprednisolone 17Gene Expression Profiling 17sargramostim 15Granulocyte Colony-Stimulating Factor 15Clofarabine 15Transplantation 14Decitabine 14Gemtuzumab 13aldesleukin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Congenital Abnormalities × Insulin × Clear all
NCT00943709 2013-08-30

Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia

Rutgers, The State University of New Jersey

Phase 3 Withdrawn
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Hyperglycemia, Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡